You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...

Citron Research’s tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company’s stock to fall as much as 9 percent ...

ST. LOUIS -- Shares of Express Scripts Inc., among the nation's largest pharmacy benefit managers, extended their 52-week high on Friday, courtesy of its expectations of a better-than-expected first ...

They're the two biggest pharmacy benefits managers in the world, and they compete against each other every day. While CVS Health boasts a higher market cap thanks to its retail pharmacies, Express ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

Last year was blah for Express Scripts Holding Company shareholders. The giant pharmacy benefit manager's stock turned in 3% gain -- well below the 21% jump from the previous year. After just a few ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...